Trial Profile
Immunogenicity and safety of fractional doses of Sanofi Pasteur's inactivated poliomyelitis vaccine administered intradermally vs full doses of inactivated poliomyelitis vaccine administered intramuscularly in healthy Philippines infants
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 21 Feb 2014
Price :
$35
*
At a glance
- Drugs Poliovirus vaccine inactivated (Primary)
- Indications Poliomyelitis
- Focus Pharmacodynamics
- Sponsors Sanofi Pasteur
- 01 Feb 2012 Results published in the International Journal of Infectious Diseases.
- 24 Mar 2010 Actual end date (Dec 2008) added as reported by ClinicalTrials.gov.
- 24 Mar 2010 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov record.